#7 - DTx Approaches To Cognitive Impairment, w/ Jordan Glenn, Chief Science Officer at Neurotrack
Failed to add items
Add to Cart failed.
Add to Wish List failed.
Remove from wishlist failed.
Adding to library failed
Follow podcast failed
Unfollow podcast failed
#7 - DTx Approaches To Cognitive Impairment, w/ Jordan Glenn, Chief Science Officer at Neurotrack
-
Narrated by:
-
By:
About this listen
Join us on the latest episode! Our Guest: Jordan Glenn, Chief Science Officer at Neurotrack
What you'll get out of this episode:
- Digital Therapeutics transforming healthcare, especially in cognitive health assessments
- Jordan Glenn shifted to cognitive health inspired by a family member's Alzheimer's battle
- Neurotrack focuses on quick, accurate digital cognitive assessments
- Implementing digital therapeutics complex but possible with flexible solutions
- Early diagnosis of cognitive impairment crucial for timely interventions
- Neurotrack offers hope and innovation in managing cognitive impairments
To learn more about Neurotrack: https://neurotrack.com/
See more of DTx Equals on our LinkedIn: https://www.linkedin.com/company/dtx-equals
See all episodes od DTx Equals: https://sliceofhealthcare.com/dtx-equals/
WHAT IS SLICE OF HEALTHCARE?
The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.